Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bioniche Pharma and Synerx Pharma have received FDA approval and have jointly launched Isosulfan Blue injection 1%.
Subscribe to our email newsletter
Bioniche Pharma and Synerx Pharma said that Isosulfan Blue injection 1% will be supplied in a carton containing six 5ml (10mg/ml) single use vials.
George Zorich, president of US operations for Bioniche Pharma, said: “Launching the generic for Isosulfan Blue injection 1% in the US allows hospitals and pharmacies an option in the buying process.”
Bioniche Pharma is a manufacturer of injectable pharmaceutical products serving a variety of niche markets, including anaesthesiology, orthopedics, rheumatology, urology, and dermatology. RoundTable Healthcare Partners, a firm based in Lake Forest, Illinois has acquired Bioniche Pharma in February 2006.
Synerx Pharma is located in Bucks County Pennsylvania. Established in January 2004, the company develops and brings to market select pharmaceutical products aimed at addressing unmet market needs, particularly those involving some combination of barriers to entry. The company is into developing cost effective specialty generic pharmaceuticals and small brand products.